Min Hwa Shin
Overview
Explore the profile of Min Hwa Shin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shin M, Oh E, Minn D
Immune Netw
. 2024 Nov;
24(5):e34.
PMID: 39513028
NK cells are specialized immune effector cells crucial for triggering immune responses against aberrant cells. Although recent advancements have concentrated on creating or releasing T-cell responses specific to tumor Ags,...
2.
Kim J, Kim T, Chae S, Ha H, Park Y, Park S, et al.
Mol Cancer
. 2024 Feb;
23(1):45.
PMID: 38424542
Background: In the myeloid compartment of the tumor microenvironment, CD244 signaling has been implicated in immunosuppressive phenotype of monocytes. However, the precise molecular mechanism and contribution of CD244 to tumor...
3.
Shin M, Oh E, Kim Y, Nam D, Jeon S, Yu J, et al.
Cells
. 2023 Jun;
12(12).
PMID: 37371075
Adoptive cell therapy using chimeric antigen receptor (CAR) technology is one of the most advanced engineering platforms for cancer immunotherapy. CAR-T cells have shown remarkable efficacy in the treatment of...
4.
Kim H, Kim J, Sa J, Ryu B, Park K, Kim J, et al.
Biomed Pharmacother
. 2022 Aug;
154:113553.
PMID: 35994815
To overcome the hurdles of immunotherapy, we investigated whether calcipotriol, a synthetic vitamin D analog, could overcome the immune evasion of glioblastoma multiforme (GBM) by modulating immune responses and the...
5.
Lim S, Moon Y, Shin M, Kim T, Chae S, Yee C, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33920906
NK cells are the predominant innate lymphocyte subsets specialized to kill malignant tumor cells. In patients with advanced cancer, hypoxic stress shapes NK cells toward tumor-resistant and immunosuppressive phenotypes, hence...
6.
Park B, Shin M, Kim J, Park G, Ryu Y, Lee J, et al.
Infect Immun
. 2021 Jan;
89(4).
PMID: 33468581
Thymosin beta-4 (Tβ4) is an actin-sequestering peptide that plays important roles in regeneration and remodeling of injured tissues. However, its function in a naturally occurring pathogenic bacterial infection model has...
7.
Shin M, Kim J, Lim S, Kim J, Kim S, Lee K
Immune Netw
. 2020 May;
20(2):e14.
PMID: 32395366
With the development of technologies that can transform immune cells into therapeutic modalities, immunotherapy has remarkably changed the current paradigm of cancer treatment in recent years. NK cells are components...
8.
Shin M, Kim J, Lim S, Kim J, Lee K
Int J Mol Sci
. 2020 Apr;
21(7).
PMID: 32260561
The recent development of high-throughput genomics has revolutionized personalized medicine by identifying key pathways and molecular targets controlling tumor progression and survival. Mitogen-activated protein kinase (MAPK) pathways are examples of...
9.
Kim T, Park G, Kim J, Lim S, Kim J, Im K, et al.
Nat Commun
. 2019 Jul;
10(1):3258.
PMID: 31332204
CD160 and BTLA both bind to herpes virus entry mediator. Although a negative regulatory function of BTLA in natural killer T (NKT) cell activation has been reported, whether CD160 is...
10.
Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al.
Front Immunol
. 2019 Apr;
10:496.
PMID: 31024520
Tumor-infiltrating lymphocytes (TILs), found in patients with advanced pancreatic ductal adenocarcinoma (PDAC), are shown to correlate with overall survival (OS) rate. Although majority of TILs consist of CD8/CD4 T cells,...